BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Cardiawave Strengthens Leadership with Appointment of Jonathan Freeman as Board Chairman

  October 24, 2025

   · 

  2 min read
• Press Releases

  LivaNova to Present at Wolfe Research Healthcare Conference in November 2025

  October 24, 2025

   · 

  1 min read
• Press Releases

  Gilead to Showcase Interim Long-Term Efficacy Data for Livdelzi® (Seladelpar) in Primary Biliary Cholangitis (PBC) and Investigational Bulevirtide in Chronic Hepatitis Delta

  October 24, 2025

   · 

  17 min read
• Press Releases

  Vertex Presents New Data Across Portfolio of Cystic Fibrosis Medicines Including ALYFTREK® at the North American Cystic Fibrosis Conference

  October 24, 2025

   · 

  15 min read
• Press Releases

  Nielsen BioSciences Announces Expanded CANDIN License Agreement with Maruho Co. Ltd.

  October 24, 2025

   · 

  3 min read
• Press Releases

  Harmony Biosciences Preannounces Strong Q3 2025 WAKIX Performance; Raises 2025 Revenue Guidance

  October 24, 2025

   · 

  11 min read
• Press Releases

  IMUNON to Present New Translational Data from Phase 2 OVATION 2 Study of IMNN-001 at SITC 40th Annual Meeting

  October 24, 2025

   · 

  9 min read
• Press Releases

  Guerbet : Revenue at September 30, 2025. Return to growth in Q3 2025. Confirmation of all financial targets for 2025.

  October 24, 2025

   · 

  7 min read
• Press Releases

  Alloy Therapeutics Announces Acquisition of Spannerwerks, a Leading Provider of Drug Development Consulting Services

  October 24, 2025

   · 

  3 min read
• Press Releases

  Nuvation Bio Enrolls First Patient in Global, Randomized Study of Safusidenib for Maintenance Treatment of High-Grade IDH1-Mutant Glioma

  October 24, 2025

   · 

  6 min read